E. Rossi

2.7k total citations
109 papers, 1.3k citations indexed

About

E. Rossi is a scholar working on Complementary and alternative medicine, Hematology and Surgery. According to data from OpenAlex, E. Rossi has authored 109 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Complementary and alternative medicine, 18 papers in Hematology and 14 papers in Surgery. Recurrent topics in E. Rossi's work include Complementary and Alternative Medicine Studies (32 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). E. Rossi is often cited by papers focused on Complementary and Alternative Medicine Studies (32 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). E. Rossi collaborates with scholars based in Italy, United States and Switzerland. E. Rossi's co-authors include Mariella Di Stefano, E Damasio, Gino Santini, Fabio Voller, F. Caredda, Andrea Bacigalupo, Fabio Firenzuoli, Maurizio Turiel, C. Créma and Piercarlo Sarzi‐Puttini and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

E. Rossi

102 papers receiving 1.2k citations

Peers

E. Rossi
Comparison fields: 5 of 115
  • Hematology 309
  • Complementary and alternative medicine 304
  • Oncology 168
  • Genetics 167
  • Pulmonary and Respiratory Medicine 166
Replace Paola de Pablo with:
Paola de Pablo United Kingdom
Jorge Neumann Brazil
Tejas Patel United States
Jayan Parameshwar United Kingdom
Wolfgang Salmhofer Austria
Susana Lopes Portugal
Félix Pérez‐Villa Spain
Mark S. Dykewicz United States
Abdurrahman Tufan Türkiye
Gökhan Keser Türkiye
Paola de Pablo United Kingdom View profile →
Citations per field, relative to E. Rossi
E. Rossi · 1×
Citations per year, relative to E. Rossi
E. Rossi · 1×

Countries citing papers authored by E. Rossi

Since Specialization
Citations

This map shows the geographic impact of E. Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Rossi more than expected).

Fields of papers citing papers by E. Rossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Rossi. The network helps show where E. Rossi may publish in the future.

Co-authorship network of co-authors of E. Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of E. Rossi. A scholar is included among the top collaborators of E. Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Rossi. E. Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 1
3 44
4 20
5 5
6 34
7 1
8 83
9 10
10 9
11 11
12 4
13 12
14
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.
24
15 15
16 2
17 22
18 15
19
Prolonged course and relapses of acute type A hepatitis.
4
20
Late recovery of renal function in a woman with the hemolytic uremic syndrome.
9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026